Prospective Study
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Nov 16, 2021; 9(32): 9869-9877
Published online Nov 16, 2021. doi: 10.12998/wjcc.v9.i32.9869
Efficacy of Yiqi Jianpi anti-cancer prescription combined with chemotherapy in patients with colorectal cancer after operation
Zheng Li, Dong-Feng Yin, Wei Wang, Xin-Wei Zhang, Li-Jiang Zhou, Jun Yang
Zheng Li, Graduate School, Liaoning University of Traditional Chinese Medicine, Shenyang 110847, Liaoning Province, China
Dong-Feng Yin, Li-Jiang Zhou, Jun Yang, Oncology Department, The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang 110032, Liaoning Province, China
Wei Wang, Xin-Wei Zhang, Department of Integrated Traditional Chinese and Western Medicine, Liaoning Cancer Hospital and Institute, Shenyang 110042, Liaoning Province, China
Author contributions: Li Z was responsible for study design, collected and analyzed the data, and drafted the manuscript; Wang W collected and analyzed the data and reviewed the manuscript; Zhang XW, Zhou LJ, and Yang J were responsible for date analysis and review of the manuscript; Yin DF was responsible for study co-design, data analysis, and critical review of the manuscript; all authors approved the final version of the manuscript to be submitted.
Institutional review board statement: The study was reviewed and approved by the institutional review board of Liaoning Cancer Hospital and Institute.
Clinical trial registration statement: This study is not registered.
Informed consent statement: All study participants, or their legal guardian, provided written consent prior to study enrollment.
Conflict-of-interest statement: There is no conflict of interest to disclose.
Data sharing statement: There is no additional data available.
CONSORT 2010 statement: The manuscript was checked and revised according to the CONSORT 2010 statement.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Dong-Feng Yin, MD, Chief Doctor, Professor, Oncology Department, The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, No. 33 Beiling Street, Shenyang 110032, Liaoning Province, China. 148003642@qq.com
Received: June 22, 2021
Peer-review started: June 22, 2021
First decision: July 5, 2021
Revised: July 16, 2021
Accepted: August 25, 2021
Article in press: August 25, 2021
Published online: November 16, 2021
Core Tip

Core Tip: In this study, the authors found that the Yiqi Jianpi anti-cancer prescription can effectively improve spleen deficiency, regulate the immune function, and alleviate the adverse effects (hand-foot skin reaction and gastrointestinal reaction) of chemotherapy, so as to improve the life quality of patients with good therapeutic effects and application prospect in clinical practice.